Publicaciones en colaboración con investigadoras/es de Instituto de Investigación Sanitaria Biocruces Bizkaia (8)

2023

  1. In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 15-26

  2. In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 1-13

2022

  1. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

    Hepatology, Vol. 76, Núm. 6, pp. 1617-1633

  2. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis

    Nature Communications, Vol. 13, Núm. 1

  3. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity

    Cancers, Vol. 14, Núm. 19

2021

  1. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

2020

  1. Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease

    Aging Cell, Vol. 19, Núm. 8

2015

  1. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves

    Journal of Cell Biology, Vol. 210, Núm. 1, pp. 153-168